1) Chung WS,
Kim MJ,
Chung YE,
Kim YE,
Park MS,
Choi JY,
Kim KW. Comparison of gadoxetic acid-enhanced dynamic imaging and diffusion-weighted imaging for the preoperative evaluation of colorectal liver metastases.
J Magn Reson Imaging.
2011 Aug;34(2):345-53.
doi: 10.1002/jmri.22671.
Epub 2011 Jun 23.
2) Kim AY,
Kim YK,
Lee MW,
Park MJ,
Hwang J,
Lee MH,
Lee JW. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.Acta Radiol.
2012 Oct 1;53(8):830-8.
doi: 10.1258/ar.2012.120099.
Epub 2012 Jul 30.
3) Kim MJ,
Rhee HJ,
Jeong HT. Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging.
AJR Am J Roentgenol.
2012 Nov; 199(5):W575-86.
4) Lee MH,
Kim SH,
Park MJ,
Park CK,
Rhim H. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.AJR Am J Roentgenol.
2011 Nov;197(5):W868-75.
doi: 10.2214/AJR.10.6237.
5) Park MJ,
Kim YK,
Lee MH,
Lee JH. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis. Acta Radiol.
2012 Nov 12.
[Epub ahead of print]
6) Wu LM,
Gu HY,
Zheng J,
Xu X,
Lin LH,
Deng X,
Zhang W,
Xu JR. Diagnostic value of whole-body magnetic resonance imaging for bone metastases: a systematic review and meta-analysis.
J Magn Reson Imaging.
2011 Jul; 34(1):128-35.
Epub 2011 May 25.
Acknowledgement to MRI technologists: Caliò A,
De Marco A,
Macrì S,
Rubino D,
Teodoro A,
Liotta A,
Alcaro PG.